Cliff Asness’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-863,513
| Closed | -$2.68M | – | 2361 |
|
|
2021
Q4 | $2.68M | Buy |
863,513
+277,928
| +47% | +$935K | ﹤0.01% | 1018 |
|
|
2021
Q3 | $2.11M | Sell |
585,585
-39,303
| -6% | -$148K | ﹤0.01% | 1112 |
|
|
2021
Q2 | $2.24M | Buy |
624,888
+21,914
| +4% | +$77.3K | ﹤0.01% | 1162 |
|
|
2021
Q1 | $2.36M | Buy |
602,974
+200,241
| +50% | +$827K | ﹤0.01% | 1127 |
|
|
2020
Q4 | $1.69M | Sell |
402,733
-21,205
| -5% | -$81.7K | ﹤0.01% | 1250 |
|
|
2020
Q3 | $1.58M | Sell |
423,938
-45,006
| -10% | -$192K | ﹤0.01% | 1209 |
|
|
2020
Q2 | $2.04M | Sell |
468,944
-45,289
| -9% | -$204K | ﹤0.01% | 1157 |
|
|
2020
Q1 | $1.95M | Buy |
514,233
+424,336
| +472% | +$2.09M | ﹤0.01% | 1085 |
|
|
2019
Q4 | $568K | Buy |
89,897
+31,889
| +55% | +$187K | ﹤0.01% | 1710 |
|
|
2019
Q3 | $244K | Buy |
+58,008
| New | +$248K | ﹤0.01% | 1962 |
|
|
2016
Q3 | – | Sell |
-12,873
| Closed | -$30K | – | 2366 |
|
|
2016
Q2 | $30K | Buy |
+12,873
| New | +$35.5K | ﹤0.01% | 2183 |
|
|
2015
Q3 | – | Sell |
-128,826
| Closed | -$1.03M | – | 2373 |
|
|
2015
Q2 | $1.03M | Sell |
128,826
-79,774
| -38% | -$685K | ﹤0.01% | 1483 |
|
|
2015
Q1 | $2.19M | Buy |
208,600
+36,300
| +21% | +$496K | 0.01% | 1068 |
|
|
2014
Q4 | $2.07M | Buy |
172,300
+107,000
| +164% | +$1.63M | ﹤0.01% | 1266 |
|
|
2014
Q3 | $1.12M | Buy |
65,300
+9,100
| +16% | +$132K | ﹤0.01% | 1555 |
|
|
2014
Q2 | $678K | Buy |
56,200
+22,200
| +65% | +$210K | ﹤0.01% | 1845 |
|
|
2014
Q1 | $287K | Buy |
+34,000
| New | +$274K | ﹤0.01% | 2282 |
|
Other funds holding BDSI
Cliff Asness's BDSI Position: Q1 2022 in Review
Cliff Asness sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 863,513 shares — an estimated $2.68M sold.
Cliff Asness first reported a position in BDSI in Q1 2014 and held it in 17 quarters. The position peaked at $2.68M in Q4 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Cliff Asness reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Cliff Asness sold 863,513 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $2.68M.
- Cliff Asness first reported a position in BioDelivery Sciences International, Inc. in Q1 2014 and held it in 17 quarters.
- Cliff Asness's BioDelivery Sciences International, Inc. position peaked at $2.68M in Q4 2021.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on AQR Capital Management's 13F filing for Q1 2022, filed 16 May 2022.